The Biocodex story started modestly, bringing Saccharomyces boulardii CNCM I-745® to market in France as a therapeutic brand named ULTRA-LEVURE®.
This single celled, non-pathogenic yeast therapeutic has since become the world’s number one yeast-based probiotic in the world.
From this scientific and commercial success, Biocodex has built its worldwide company into a diverse pharmaceutical organization with an international portfolio of products.
Biocodex's products are available in over 100 countries on 5 continents with a network of 9 affiliates and 112 partners. To know more about our affiliates' products, please select your country.